TP53 and small cell lung carcinoma: For example, both SCLC and NEPC exhibit concurrent genetic loss of tumor suppressors RB1 and TP53, as well as mutually exclusive expression of C‐MYC (MYC), N‐MYC (MYCN) or L‐MYC (MYCL).11